Elsevier acquires Via Oncology, UPMC decision support spinoff

Elsevier this week announced its acquisition of Pittsburgh-based Via Oncology, a former subsidiary of UPMC that develops clinical decision support tools for cancer care management. Via Oncology’s technology helps cancer centers demonstrate the value of their care to patients, physicians and payers by developing and implementing clinical pathways in collaboration with its network of more than 1,500 cancer care providers.

Powered by WPeMatico